- Diagnostic Devices
- Therapeutic Devices
- Sleep Apnea Masks
Sleep Apnea Devices Market size was valued at USD 5.6 billion in 2022 and is poised to grow at a CAGR of 6.2% from 2023-2029. Global Sleep Apnea Devices market is a chronic disorder, characterized with repetitive obstructions in breathing during sleep. Major symptoms include snoring, gasping or choking. Long-term health problems associated with OSA include cardiovascular disorders, memory and cognitive problems, glaucoma, depression and mood disorders. Polysomnography and portable home sleep diagnostic devices are enabling diagnose the Obstructive sleep apnea (OSA). First line therapy for involves positive airway devices (PAP). If patients do not respond to the PAP therapy, second-line treatment includes dental appliances and surgery. Rapid traction in the global geriatric population coupled with increased obesity levels enables to increase the prevalence of sleep apnea. The world is experiencing growth in the number and proportion of old age people. As per WHO, the number of people aged 60 years or over is projected to grow approximately 56 % between 2015 to 2030. According to estimates, a prevalence of OSA is approximately 3% to 7% of the adult men and 2 to 5% of adult women. Moreover, 80% of the patients with moderate to severe sleep apnea may be undiagnosed.
Sleep Apnea Devices Market key Developments:
- In August 2016, Fisher & Paykel Healthcare launched F&P Brevida nasal pillow mask for the treatment of OSA. The product will be initially available in Australia & New Zealand followed by Canada and Europe
Sleep Apnea Devices Market Summary
Study Period
2023-29
Base Year
2022
CAGR
6.2%
Largest Market
North America
Fastest Growing Market
Asia Pacific
Sleep Apnea Devices Market Dynamics
Therapeutic sleep apnea devices market expected to expand at significant CAGR due to the adoption of advanced technologies to treat OSA. CPAP devices are most commonly used devices to treat OSA, the pressure delivered to the airway is same during both inhalation and exhalation. Diagnostic devices include polysomnography, respiratory polygraph devices. Actigraph devices are expected to expand at significant CAGR. These devices enable measure motions of the body and assess real-world sleep/ wake patterns.
North-America Got Significant Share of
Sleep Apnea Devices Market Regional Analysis
Sleep apnea device market has been segmented into following regions such as North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. U.S. is accounted for the majority of market share in 2015, expected to continue is revenue share in North America, owing to large patient pool in the country. In accordance with National Sleep Foundation statistics, about 18 million people in the U.S. suffered from sleep apnea in 2012. Favourable reimbursements policies for sleep apnea devices are enabling accelerate the market. For instance, Medicare reimbursement offers the US $ 103.42 for CPAP device, HCPCS-E0601. Europe market is driven by government initiatives to increase awareness about sleep apnea, adoption of novel treatment options able to create lucrative opportunities over the forecast period. As per European Sleep Apnea Database (ESADA) 2011, Prevalence of sleep apnea is around 2% of adult female and 4% of adult male. Sleep apnea is associated with the impaired neuropsychological function, reduced social functioning, and quality of life. The UK is accounted the majority of market share due to increased prevalence of sleep apnea coupled with favorable government policies and reimbursement scenario. Asia-Pacific offers lucrative opportunities due to increased medical tourism in the emerging countries such as South Korea, China, and India. Adoption of cutting-edge technologies coupled with cost-effective treatments enables witness for unlocking the potential of Global sleep apnea devices market.
Latin America
Europe
Asia Pacific
Middle East
North America
Key Features of the Reports
- The sleep apnea devices market report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
- The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments and startup’s details that are actively working in the market
- The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
- The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
Sleep Apnea Devices Market Segmentation
By Type
By End User
- Home Care Settings/Individuals,
- Sleep Laboratories &
- Hospitals
By Geography
- APAC
- North America
- Latin
- Europe
- MEA
Frequently Asked Questions
The sleep apnea devices market size was valued at USD 5.6 billion in 2022
The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).
The sleep apnea devices market key players are SomnoMed Ltd., ResMed, Inc, Philips Healthcare, Fisher & Paykel Healthcare Ltd.
| 1.Executive Summary |
| 2.Global Sleep Apnea Devices Market Introduction |
| 2.1.Global Sleep Apnea Devices Market - Taxonomy |
| 2.2.Global Sleep Apnea Devices Market - Definitions |
| 2.2.1. Type |
| 2.2.2.End User |
| 2.2.3.Geography |
| 2.2.4.Region |
| 3.Global Sleep Apnea Devices Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4.Global Sleep Apnea Devices Market Analysis, 2018 - 2022 and Forecast 2023 - 2029 |
| 4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5.Global Sleep Apnea Devices Market By Type , 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 5.1. Diagnostic Devices |
| 5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Therapeutic Devices |
| 5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Sleep Apnea Masks |
| 5.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 6.Global Sleep Apnea Devices Market By End User, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 6.1. Home Care Settings/Individuals, |
| 6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Sleep Laboratories & |
| 6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Hospitals |
| 6.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 7.Global Sleep Apnea Devices Market By Geography, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 7.1. APAC |
| 7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. North America |
| 7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Latin |
| 7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Europe |
| 7.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 7.5. MEA |
| 7.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.5.3. Market Opportunity Analysis |
| 8.Global Sleep Apnea Devices Market By Region, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 8.1. North America |
| 8.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Europe |
| 8.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Asia Pacific (APAC) |
| 8.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Middle East and Africa (MEA) |
| 8.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 8.5. Latin America |
| 8.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.5.3. Market Opportunity Analysis |
| 9.North America Sleep Apnea Devices Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 9.1. Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1.Diagnostic Devices |
| 9.1.2.Therapeutic Devices |
| 9.1.3.Sleep Apnea Masks |
| 9.2. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1.Home Care Settings/Individuals, |
| 9.2.2.Sleep Laboratories & |
| 9.2.3.Hospitals |
| 9.3. Geography Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1.APAC |
| 9.3.2.North America |
| 9.3.3.Latin |
| 9.3.4.Europe |
| 9.3.5.MEA |
| 9.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.4.1.United States of America (USA) |
| 9.4.2.Canada |
| 10.Europe Sleep Apnea Devices Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 10.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Diagnostic Devices |
| 10.1.2.Therapeutic Devices |
| 10.1.3.Sleep Apnea Masks |
| 10.2. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Home Care Settings/Individuals, |
| 10.2.2.Sleep Laboratories & |
| 10.2.3.Hospitals |
| 10.3. Geography Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.APAC |
| 10.3.2.North America |
| 10.3.3.Latin |
| 10.3.4.Europe |
| 10.3.5.MEA |
| 10.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Germany |
| 10.4.2.France |
| 10.4.3.Italy |
| 10.4.4.United Kingdom (UK) |
| 10.4.5.Spain |
| 10.4.6.Rest of EU |
| 11.Asia Pacific (APAC) Sleep Apnea Devices Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 11.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Diagnostic Devices |
| 11.1.2.Therapeutic Devices |
| 11.1.3.Sleep Apnea Masks |
| 11.2. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Home Care Settings/Individuals, |
| 11.2.2.Sleep Laboratories & |
| 11.2.3.Hospitals |
| 11.3. Geography Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.APAC |
| 11.3.2.North America |
| 11.3.3.Latin |
| 11.3.4.Europe |
| 11.3.5.MEA |
| 11.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.China |
| 11.4.2.India |
| 11.4.3.Australia and New Zealand (ANZ) |
| 11.4.4.Japan |
| 11.4.5.Rest of APAC |
| 12.Middle East and Africa (MEA) Sleep Apnea Devices Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 12.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Diagnostic Devices |
| 12.1.2.Therapeutic Devices |
| 12.1.3.Sleep Apnea Masks |
| 12.2. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Home Care Settings/Individuals, |
| 12.2.2.Sleep Laboratories & |
| 12.2.3.Hospitals |
| 12.3. Geography Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.APAC |
| 12.3.2.North America |
| 12.3.3.Latin |
| 12.3.4.Europe |
| 12.3.5.MEA |
| 12.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.GCC Countries |
| 12.4.2.South Africa |
| 12.4.3.Rest of MEA |
| 13.Latin America Sleep Apnea Devices Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 13.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Diagnostic Devices |
| 13.1.2.Therapeutic Devices |
| 13.1.3.Sleep Apnea Masks |
| 13.2. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Home Care Settings/Individuals, |
| 13.2.2.Sleep Laboratories & |
| 13.2.3.Hospitals |
| 13.3. Geography Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.APAC |
| 13.3.2.North America |
| 13.3.3.Latin |
| 13.3.4.Europe |
| 13.3.5.MEA |
| 13.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Brazil |
| 13.4.2.Mexico |
| 13.4.3.Rest of LA |
| 14. Competition Landscape |
| 14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 14.2.1.SomnoMed Ltd. |
| 14.2.2.ResMed, Inc |
| 14.2.3.Philips Healthcare |
| 14.2.4.Fisher & Paykel Healthcare Ltd. |
| 14.2.5.Compumedics Limited |
| 14.2.6.Braebon Medical Corporation |
| 14.2.7.Weinmann Medical Devices GmbH |
| 14.2.8.BMC Medical Co., Ltd |
| 14.2.9.DeVilbiss Healthcare |
| 15. Research Methodology |
| 16. Appendix and Abbreviations |
- SomnoMed Ltd.
- ResMed, Inc
- Philips Healthcare
- Fisher & Paykel Healthcare Ltd.
- Compumedics Limited
- Braebon Medical Corporation
- Weinmann Medical Devices GmbH
- BMC Medical Co., Ltd
- DeVilbiss Healthcare